"Johnson & Johnson MedTech announces partnership for soft tissue solutions" was originally created and published by Medical ...

Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some ...

Johnson & Johnson has a high three-year median payout ratio of 71% (or a retention ratio of 29%), meaning that the company is ...

Companies with a long history of paying dividends and consistently hiking them remain appealing to income-focused investors.

However, HRSA resisted the plan, threatening to terminate Johnson & Johnson’s PPA and impose significant penalties. This ...

Johnson & Johnson shows strong progress in oncology with Darzalex sales and regulatory filings, leading to a 'Buy' rating ...

Johnson & Johnson MedTech announced today that the FDA granted its Ottava surgical robot investigational device exemption ...

J&J wants to appoint lawyer Randi Ellis, who helped it prepare for its third talc-related chapter 11 filing, but the U.S.

Johnson & Johnson MedTech announced today that it entered into an exclusive commercial distribution agreement with Responsive Arthroscopy. The company agreed to a deal in the U.S. with Responsive ...

Johnson & Johnson MedTech has entered into an exclusive commercial distribution agreement with Responsive Arthroscopy, a medical device company specializing in sports soft tissue repair solutions. The ...

Johnson & Johnson announced results from additional analyses ... These data were included in a plenary session presentation and two posters and are among the Company’s 43 oral and poster presentations ...